Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants

Annals of Neurology
N L FosterS Gilman

Abstract

We held an international consensus conference on frontotemporal dementia, behavioral disturbances, and parkinsonism linked to chromosome 17 to determine whether these are homogeneous or heterogeneous disorders, to agree on terminology, and to develop strategies for further research. The group identified 13 kindreds with sufficient evidence for linkage, finding in common to all a critical 2 cM between markers D17S791 and D17S800. There was agreement that (1) despite previous descriptions that have emphasized one or another clinical or neuropathological feature, the kindreds share clinical and neuropathological features; (2) until more specific information about the genetic defects becomes available, this disorder is best termed frontotemporal dementia and parkinsonism linked to chromosome 17; and (3) further research will be enhanced by identifying the gene or genes responsible for this disorder, detecting additional cases within known families and, in new families, correlating mutations with phenotypes and more fully delineating the clinical, neuropsychological, and neuropathological characteristics of this disorder.

References

Apr 1, 1992·Neurology·M F MendezW H Frey
Sep 1, 1987·Archives of Gerontology and Geriatrics·A Brun
Nov 1, 1986·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A W ClarkJ T Coyle
Oct 1, 1968·Journal of Neurology, Neurosurgery, and Psychiatry·H H Schaumburg, K Suzuki
Mar 1, 1981·Brain : a Journal of Neurology·R C KimY B Chu
Oct 1, 1995·Brain : a Journal of Neurology·J G de YébenesA J Lees
Jun 1, 1995·Neurology·R B PetersenT ] Lynches T [corrected to Lynch
Sep 1, 1994·Neurology·D J LanskaW R Markesbery
Sep 1, 1995·Human Molecular Genetics·J BrownJ Collinge
Jun 1, 1996·Annals of Neurology·A A SimaK C Wilhelmsen
Mar 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·T GasserX O Breakefield
Oct 1, 1996·Neurology·G HusseinG Montouris
Feb 1, 1997·The Australian and New Zealand Journal of Psychiatry·F Dark
Dec 1, 1959·Annals of Human Genetics·V W SCHENK
Jul 1, 1995·Parkinsonism & Related Disorders·M A Denson, Z K Wszolek

❮ Previous
Next ❯

Citations

Sep 11, 1999·Annals of Neurology·K MarkopoulouB A Chase
Oct 8, 1999·Annals of Neurology·J C van SwietenP Heutink
Apr 13, 2000·Annals of Neurology·M Hutton
Feb 28, 2001·Annals of Neurology·T D Bird, G D Schellenberg
Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·H R MorrisN W Wood
Mar 29, 2002·Annals of Neurology·Shintaro HayashiHitoshi Takahashi
Jul 2, 2003·Annals of Neurology·Thomas BirdMichael Hutton
Jul 2, 2003·Annals of Neurology·Michael J StrongWencheng Yang
Oct 24, 1997·Annals of Neurology·L A ReedJ Q Trojanowski
Jun 18, 1998·Annals of Neurology·P PoorkajG D Schellenberg
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·A R BentivoglioA Albanese
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Katrina Gwinn-Hardy
Apr 11, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J M HendersonG M Halliday
Aug 2, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·Z K WszolekR F Pfeiffer
Jun 19, 2007·Acta Neuropathologica·David Mann
Nov 8, 2011·Acta Neuropathologica·Juan F ReyesLester I Binder
Aug 15, 2012·Acta Neuropathologica·Anne SiebenMarc Cruts
Jun 9, 2005·Journal of Neurology·Giorgio GiacconeFabrizio Tagliavini
Mar 24, 2005·Journal of Neural Transmission·A Krygowska-WajsZ K Wszolek
Sep 22, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maura GalloAmalia Cecilia Bruni
Apr 18, 2009·Apoptosis : an International Journal on Programmed Cell Death·Bingwei Lu
Sep 4, 2007·Current Neurology and Neuroscience Reports·Rosa Rademakers, Mike Hutton
Jun 1, 2011·Journal of Molecular Neuroscience : MN·Alexandra M NicholsonRosa Rademakers
Dec 15, 2012·Molecular Neurobiology·Gernot KleinbergerChristine Van Broeckhoven
May 26, 2004·Archives of Gerontology and Geriatrics·L RampelloF Nicoletti
Mar 10, 2004·Neurobiology of Disease·Manuela GrazinaCatarina Oliveira
Apr 2, 2004·Neurobiology of Disease·Cindy ZehrMike Hutton
May 21, 2005·Neurobiology of Aging·L BernardiA C Bruni
May 10, 2005·Parkinsonism & Related Disorders·Yasuhiko BabaZbigniew K Wszolek
Nov 15, 2000·Disease-a-month : DM·D A Bennett
Jun 24, 2000·Journal of the Neurological Sciences·K KodamaT Sato

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.